Leading Australian scientists are at the forefront of a foundational shift in oncology after overseeing a world-first clinical trial that could fundamentally change global cancer treatment.
Led by former Australian of the Year Professor Georgina Long, the trial involved deploying an mRNA-based vaccine designed to decrease the risk of melanoma returning in patients who had it surgically removed.